We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.9B
AUM Growth
+$373M
Cap. Flow
+$123M
Cap. Flow %
0.82%
Top 10 Hldgs %
56.71%
Holding
1,166
New
198
Increased
342
Reduced
449
Closed
173

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$32M
2
AVGO icon
Broadcom
AVGO
+$31.6M
3
VZ icon
Verizon
VZ
+$27.3M
4
CCJ icon
Cameco
CCJ
+$26.1M
5
MPLX icon
MPLX
MPLX
+$23.1M

Sector Composition

Rank Sector Weight
1 Energy 66.42%
2 Technology 4.66%
3 Financials 3.55%
4 Consumer Discretionary 3.47%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVM
976
Silvercorp Metals
SVM
$2.13B
$224K ﹤0.01%
51,257
+18,017
+54% +$66.8K
AVIR icon
977
Atea Pharmaceuticals
AVIR
$379M
$217K ﹤0.01%
64,692
-986
-2% -$3.58K
ZNTL icon
978
Zentalis Pharmaceuticals
ZNTL
$308M
$207K ﹤0.01%
56,216
+802
+1% +$2.92K
VNDA icon
979
Vanda Pharmaceuticals
VNDA
$312M
$207K ﹤0.01%
44,036
-1,360
-3% -$7.29K
PROK icon
980
ProKidney
PROK
$308M
$187K ﹤0.01%
97,396
+47,548
+95% +$108K
BVN icon
981
Compañía de Minas Buenaventura
BVN
$7.85B
$186K ﹤0.01%
+13,410
New +$194K
INBX icon
982
Inhibrx
INBX
$1.2B
$172K ﹤0.01%
10,952
-324
-3% -$4.55K
ENTA icon
983
Enanta Pharmaceuticals
ENTA
$372M
$166K ﹤0.01%
16,038
-484
-3% -$6.33K
KYTX icon
984
Kyverna Therapeutics
KYTX
$450M
$162K ﹤0.01%
33,056
-573
-2% -$4.42K
SLI
985
Standard Lithium
SLI
$517M
$151K ﹤0.01%
94,054
+17,593
+23% +$22.7K
TMQ
986
Trilogy Metals
TMQ
$522M
$144K ﹤0.01%
297,298
+19,839
+7% +$11K
VZLA
987
Vizsla Silver
VZLA
$1.16B
$115K ﹤0.01%
59,766
+20,992
+54% +$40.5K
PLL
988
DELISTED
Piedmont Lithium
PLL
$89.9K ﹤0.01%
10,065
-31,259
-76% -$282K
HLVX
989
DELISTED
HilleVax
HLVX
$66.4K ﹤0.01%
37,705
-1,082
-3% -$2.77K
GRAB icon
990
Grab
GRAB
$13.5B
$66.3K ﹤0.01%
17,448
+1,300
+8% +$4.43K
ASM
991
Avino Silver & Gold Mines
ASM
$987M
$37.2K ﹤0.01%
33,796
+11,876
+54% +$12K
NEWP
992
New Pacific Metals
NEWP
$833M
$35.7K ﹤0.01%
23,945
+8,409
+54% +$12.2K
ABAT icon
993
American Battery Technology Co
ABAT
$301M
$15.9K ﹤0.01%
+14,880
New +$15.5K
ACCO icon
994
Acco Brands
ACCO
$369M
-72,759
Closed -$342K
ADM icon
995
Archer Daniels Midland
ADM
$41.4B
-15,672
Closed -$947K
AGM icon
996
Federal Agricultural Mortgage
AGM
$2.27B
-1,828
Closed -$331K
AGYS icon
997
Agilysys
AGYS
$2.78B
-4,795
Closed -$499K
ALG icon
998
Alamo Group
ALG
$2.01B
-1,710
Closed -$296K
AMLX icon
999
Amylyx Pharmaceuticals
AMLX
$2.05B
-90,357
Closed -$172K
AMR icon
1000
Alpha Metallurgical Resources
AMR
$1.82B
-1,000
Closed -$281K

Similar funds

ALPS Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, ALPS Advisors held 1,166 positions worth $14.9B, up 2.6% from $14.6B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

ALPS Advisors's Q3 2024 filing shows 198 new, 342 increased, 449 reduced and 173 closed positions. Its largest new stake was LyondellBasell Industries: 258,651 shares worth $24.8M. The largest sale was JPMorgan Chase, an estimated $32M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 69% a quarter earlier, followed by Technology and Financials.

  • ALPS Advisors's largest Q3 2024 buy was LyondellBasell Industries: 258,651 shares worth $24.8M.
  • ALPS Advisors added most to ENLINK MIDSTREAM, LLC in Q3 2024, an estimated $48.3M increase.
  • ALPS Advisors's biggest Q3 2024 reduction was JPMorgan Chase, cutting an estimated $32M.
  • ALPS Advisors fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $14.5M.
  • ALPS Advisors's ten largest holdings make up 57% of its $14.9B portfolio in Q3 2024.
  • ALPS Advisors opened 198 new positions and closed 173 in Q3 2024.
  • ALPS Advisors's portfolio value rose 2.6% quarter-over-quarter to $14.9B.

Based on ALPS Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.